FI851170A7 - Spiro-indeenit ja spiro-1,2 -dihydronaftaleenit sokeritaudin komplikaatioiden hoitoon. - Google Patents

Spiro-indeenit ja spiro-1,2 -dihydronaftaleenit sokeritaudin komplikaatioiden hoitoon. Download PDF

Info

Publication number
FI851170A7
FI851170A7 FI851170A FI851170A FI851170A7 FI 851170 A7 FI851170 A7 FI 851170A7 FI 851170 A FI851170 A FI 851170A FI 851170 A FI851170 A FI 851170A FI 851170 A7 FI851170 A7 FI 851170A7
Authority
FI
Finland
Prior art keywords
spiro
dihydronaphthalenes
indenes
treatment
diabetic complications
Prior art date
Application number
FI851170A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI851170A0 (fi
FI851170L (fi
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI851170A0 publication Critical patent/FI851170A0/fi
Publication of FI851170L publication Critical patent/FI851170L/fi
Publication of FI851170A7 publication Critical patent/FI851170A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI851170A 1984-03-23 1985-03-22 Spiro-indeenit ja spiro-1,2 -dihydronaftaleenit sokeritaudin komplikaatioiden hoitoon. FI851170A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59301284A 1984-03-23 1984-03-23

Publications (3)

Publication Number Publication Date
FI851170A0 FI851170A0 (fi) 1985-03-22
FI851170L FI851170L (fi) 1985-09-24
FI851170A7 true FI851170A7 (fi) 1985-09-24

Family

ID=24372993

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851170A FI851170A7 (fi) 1984-03-23 1985-03-22 Spiro-indeenit ja spiro-1,2 -dihydronaftaleenit sokeritaudin komplikaatioiden hoitoon.

Country Status (15)

Country Link
EP (1) EP0159143B1 (enExample)
JP (1) JPS60209572A (enExample)
KR (1) KR850006188A (enExample)
AU (1) AU563668B2 (enExample)
CA (1) CA1244443A (enExample)
DE (1) DE3561198D1 (enExample)
DK (1) DK131885A (enExample)
ES (1) ES8606295A1 (enExample)
FI (1) FI851170A7 (enExample)
GR (1) GR850704B (enExample)
HU (1) HU195783B (enExample)
IL (1) IL74667A (enExample)
PH (1) PH23921A (enExample)
PL (1) PL145198B1 (enExample)
PT (1) PT80145B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
AU2004222328B2 (en) 2003-03-14 2009-10-08 Merck Sharp & Dohme Corp. Aryl spirohydantoin CGRP receptor antagonists
AU2005285083B2 (en) * 2004-09-13 2011-03-10 Merck Sharp & Dohme Corp. Tricyclic anilide spirohydantoin CGRP receptor antagonists
CA2629406A1 (en) 2005-11-18 2007-05-31 Merck & Co., Inc. Spirohydantoin aryl cgrp receptor antagonists
CN111732545B (zh) * 2020-06-08 2023-03-10 华侨大学 一种2,3-二氢螺[咪唑-4,1′-茚]类化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
ES8400116A1 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications

Also Published As

Publication number Publication date
HU195783B (en) 1988-07-28
HUT37603A (en) 1986-01-23
FI851170A0 (fi) 1985-03-22
FI851170L (fi) 1985-09-24
JPS60209572A (ja) 1985-10-22
DE3561198D1 (en) 1988-01-28
DK131885A (da) 1985-09-24
ES8606295A1 (es) 1986-04-16
GR850704B (enExample) 1985-07-19
DK131885D0 (da) 1985-03-22
CA1244443A (en) 1988-11-08
PL252487A1 (en) 1985-10-08
PH23921A (en) 1990-01-23
ES541450A0 (es) 1986-04-16
IL74667A0 (en) 1985-06-30
PT80145B (en) 1987-03-23
AU4025185A (en) 1985-09-26
EP0159143B1 (en) 1987-12-16
IL74667A (en) 1988-12-30
AU563668B2 (en) 1987-07-16
PT80145A (en) 1985-04-01
PL145198B1 (en) 1988-08-31
KR850006188A (ko) 1985-10-02
EP0159143A1 (en) 1985-10-23

Similar Documents

Publication Publication Date Title
NO167122C (no) Implanterbar kneprotese.
DE3587271D1 (de) Blutfilter.
FI854488L (fi) Kontrastmedel.
FI852123A0 (fi) Inotropiska, kinoloninbaserade aemnen.
FI853635L (fi) Oftalmologiskt instrument foer maetning av oegats interna vaetsketryck.
FI850627A0 (fi) En pappersmaskin-press med foerlaengt nyp.
FI851633A0 (fi) Kirurgiskt reparationsnaet.
DE3676746D1 (de) Lanzette.
DE3875749D1 (de) Absorbierende zusammensetzung.
DE3750239D1 (de) Katheter.
DE3678932D1 (de) Katheter.
FI874671A0 (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
FI884448L (fi) Blodtagningsventil.
FI850946A0 (fi) Medicinska plaoster.
FI853249L (fi) Cdna-kloner foer human erytropoietin.
DE3586148D1 (de) Flaechenbehandlungsverfahren.
NO844037L (no) Tannbehandlingspreparat inneholdende fluoridioner.
FI850266A7 (fi) Atsolyyliaryylialkanolijohdoksia, menetelmä niiden valmistamiseksi ja niiden käyttö.
FI854931L (fi) Behandling av avloppsvatten.
FI853977A0 (fi) Icke-metallisk kirurgisk taong.
FI870944L (fi) Ytbehandlingsfoerfarande.
FI853205L (fi) Foerfarande foer framstaellning av formstycken av gips, saerskilt plattor.
FI853621A7 (fi) Vinyylitetrasolyylifenyyli-johdannaisia, niiden valmistus ja käyttö.
DE3583611D1 (de) Transtrachealkatheteranordnung.
DE3561198D1 (en) Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: PFIZER INC.